Copy number variations in primary tumor, serum and lymph node metastasis of bladder cancer patients treated with radical cystectomy

Abstract The aim of the present study was to analyze copy number variations (CNV) of multiple oncogenes and tumor suppressor genes in genomic DNA from primary tumor tissue, lymph node metastasis and cell-free DNA (cfDNA) from serum of 72 urothelial carcinoma of bladder (UCB) patients treated with ra...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Armin Soave, Lan Kluwe, Hang Yu, Michael Rink, Philipp Gild, Malte W. Vetterlein, Philipp Marks, Guido Sauter, Margit Fisch, Christian P. Meyer, Tim Ludwig, Roland Dahlem, Sarah Minner, Klaus Pantel, Bettina Steinbach, Heidi Schwarzenbach
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2020
Materias:
R
Q
Acceso en línea:https://doaj.org/article/5505756bedc747a0b0d401f3350bbc48
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:5505756bedc747a0b0d401f3350bbc48
record_format dspace
spelling oai:doaj.org-article:5505756bedc747a0b0d401f3350bbc482021-12-02T11:43:36ZCopy number variations in primary tumor, serum and lymph node metastasis of bladder cancer patients treated with radical cystectomy10.1038/s41598-020-75869-x2045-2322https://doaj.org/article/5505756bedc747a0b0d401f3350bbc482020-12-01T00:00:00Zhttps://doi.org/10.1038/s41598-020-75869-xhttps://doaj.org/toc/2045-2322Abstract The aim of the present study was to analyze copy number variations (CNV) of multiple oncogenes and tumor suppressor genes in genomic DNA from primary tumor tissue, lymph node metastasis and cell-free DNA (cfDNA) from serum of 72 urothelial carcinoma of bladder (UCB) patients treated with radical cystectomy (RC), using multiplex ligation-dependent probe amplification (MLPA). We hypothesized that primary tumor and lymph node metastasis show similar CNV profiles, and CNV are more present in lymph node metastasis compared to primary tumor tissue. Samples from 43 (59.7%) patients could be analyzed. In total, 35 (83%), 26 (68%) and 8 (42%) patients had CNV in primary tumor, serum and lymph node metastasis, respectively. MYC, CCND1, ERBB2 and CCNE1 displayed the most frequent amplifications. In particular, CNV in ERBB2 was associated with aggressive tumor characteristics. CNV in both ERBB2 and TOP2A were risk factors for disease recurrence. The current findings show that CNV are present in various oncogenes and tumor suppressor genes in genomic DNA from primary tumor, lymph node metastasis and cfDNA from serum. CNV were more present in genomic DNA from primary tumor tissue compared to cfDNA from serum and genomic DNA from lymph node metastasis. Patients with CNV in ERBB2 and TOP2A are at increased risk for disease recurrence following RC. Further studies are necessary to validate, whether these genes may represent promising candidates for targeted-therapy.Armin SoaveLan KluweHang YuMichael RinkPhilipp GildMalte W. VetterleinPhilipp MarksGuido SauterMargit FischChristian P. MeyerTim LudwigRoland DahlemSarah MinnerKlaus PantelBettina SteinbachHeidi SchwarzenbachNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 10, Iss 1, Pp 1-13 (2020)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Armin Soave
Lan Kluwe
Hang Yu
Michael Rink
Philipp Gild
Malte W. Vetterlein
Philipp Marks
Guido Sauter
Margit Fisch
Christian P. Meyer
Tim Ludwig
Roland Dahlem
Sarah Minner
Klaus Pantel
Bettina Steinbach
Heidi Schwarzenbach
Copy number variations in primary tumor, serum and lymph node metastasis of bladder cancer patients treated with radical cystectomy
description Abstract The aim of the present study was to analyze copy number variations (CNV) of multiple oncogenes and tumor suppressor genes in genomic DNA from primary tumor tissue, lymph node metastasis and cell-free DNA (cfDNA) from serum of 72 urothelial carcinoma of bladder (UCB) patients treated with radical cystectomy (RC), using multiplex ligation-dependent probe amplification (MLPA). We hypothesized that primary tumor and lymph node metastasis show similar CNV profiles, and CNV are more present in lymph node metastasis compared to primary tumor tissue. Samples from 43 (59.7%) patients could be analyzed. In total, 35 (83%), 26 (68%) and 8 (42%) patients had CNV in primary tumor, serum and lymph node metastasis, respectively. MYC, CCND1, ERBB2 and CCNE1 displayed the most frequent amplifications. In particular, CNV in ERBB2 was associated with aggressive tumor characteristics. CNV in both ERBB2 and TOP2A were risk factors for disease recurrence. The current findings show that CNV are present in various oncogenes and tumor suppressor genes in genomic DNA from primary tumor, lymph node metastasis and cfDNA from serum. CNV were more present in genomic DNA from primary tumor tissue compared to cfDNA from serum and genomic DNA from lymph node metastasis. Patients with CNV in ERBB2 and TOP2A are at increased risk for disease recurrence following RC. Further studies are necessary to validate, whether these genes may represent promising candidates for targeted-therapy.
format article
author Armin Soave
Lan Kluwe
Hang Yu
Michael Rink
Philipp Gild
Malte W. Vetterlein
Philipp Marks
Guido Sauter
Margit Fisch
Christian P. Meyer
Tim Ludwig
Roland Dahlem
Sarah Minner
Klaus Pantel
Bettina Steinbach
Heidi Schwarzenbach
author_facet Armin Soave
Lan Kluwe
Hang Yu
Michael Rink
Philipp Gild
Malte W. Vetterlein
Philipp Marks
Guido Sauter
Margit Fisch
Christian P. Meyer
Tim Ludwig
Roland Dahlem
Sarah Minner
Klaus Pantel
Bettina Steinbach
Heidi Schwarzenbach
author_sort Armin Soave
title Copy number variations in primary tumor, serum and lymph node metastasis of bladder cancer patients treated with radical cystectomy
title_short Copy number variations in primary tumor, serum and lymph node metastasis of bladder cancer patients treated with radical cystectomy
title_full Copy number variations in primary tumor, serum and lymph node metastasis of bladder cancer patients treated with radical cystectomy
title_fullStr Copy number variations in primary tumor, serum and lymph node metastasis of bladder cancer patients treated with radical cystectomy
title_full_unstemmed Copy number variations in primary tumor, serum and lymph node metastasis of bladder cancer patients treated with radical cystectomy
title_sort copy number variations in primary tumor, serum and lymph node metastasis of bladder cancer patients treated with radical cystectomy
publisher Nature Portfolio
publishDate 2020
url https://doaj.org/article/5505756bedc747a0b0d401f3350bbc48
work_keys_str_mv AT arminsoave copynumbervariationsinprimarytumorserumandlymphnodemetastasisofbladdercancerpatientstreatedwithradicalcystectomy
AT lankluwe copynumbervariationsinprimarytumorserumandlymphnodemetastasisofbladdercancerpatientstreatedwithradicalcystectomy
AT hangyu copynumbervariationsinprimarytumorserumandlymphnodemetastasisofbladdercancerpatientstreatedwithradicalcystectomy
AT michaelrink copynumbervariationsinprimarytumorserumandlymphnodemetastasisofbladdercancerpatientstreatedwithradicalcystectomy
AT philippgild copynumbervariationsinprimarytumorserumandlymphnodemetastasisofbladdercancerpatientstreatedwithradicalcystectomy
AT maltewvetterlein copynumbervariationsinprimarytumorserumandlymphnodemetastasisofbladdercancerpatientstreatedwithradicalcystectomy
AT philippmarks copynumbervariationsinprimarytumorserumandlymphnodemetastasisofbladdercancerpatientstreatedwithradicalcystectomy
AT guidosauter copynumbervariationsinprimarytumorserumandlymphnodemetastasisofbladdercancerpatientstreatedwithradicalcystectomy
AT margitfisch copynumbervariationsinprimarytumorserumandlymphnodemetastasisofbladdercancerpatientstreatedwithradicalcystectomy
AT christianpmeyer copynumbervariationsinprimarytumorserumandlymphnodemetastasisofbladdercancerpatientstreatedwithradicalcystectomy
AT timludwig copynumbervariationsinprimarytumorserumandlymphnodemetastasisofbladdercancerpatientstreatedwithradicalcystectomy
AT rolanddahlem copynumbervariationsinprimarytumorserumandlymphnodemetastasisofbladdercancerpatientstreatedwithradicalcystectomy
AT sarahminner copynumbervariationsinprimarytumorserumandlymphnodemetastasisofbladdercancerpatientstreatedwithradicalcystectomy
AT klauspantel copynumbervariationsinprimarytumorserumandlymphnodemetastasisofbladdercancerpatientstreatedwithradicalcystectomy
AT bettinasteinbach copynumbervariationsinprimarytumorserumandlymphnodemetastasisofbladdercancerpatientstreatedwithradicalcystectomy
AT heidischwarzenbach copynumbervariationsinprimarytumorserumandlymphnodemetastasisofbladdercancerpatientstreatedwithradicalcystectomy
_version_ 1718395341530726400